Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hydrogen's Feasibility and Safety as a Therapy in Extracorporeal Cardiopulmonary Resuscitation

NCT05574296 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT05574296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05574296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hydrogen's Feasibility and Safety as a Therapy in Extracorporeal Cardiopulmonary Resuscitation
Lead sponsor
Boston Children's Hospital
Phase
Phase 1
Overall status
Recruiting
Start date
March 4, 2024
Completion date
August 31, 2027
Enrollment
53 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, extracorporeal membrane oxygenation, reperfusion injury